PACB Files 8-K on Operations and Financials
Ticker: PACB · Form: 8-K · Filed: May 8, 2025 · CIK: 1299130
Sentiment: neutral
Topics: operations, financials, sec-filing
Related Tickers: PACB
TL;DR
PACB filed an 8-K. Standard ops and financials update.
AI Summary
On May 8, 2025, Pacific Biosciences of California, Inc. (PACB) filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or significant events were detailed in the provided excerpt.
Why It Matters
This 8-K filing indicates that Pacific Biosciences of California, Inc. is providing updates on its operational and financial status to the SEC. Investors and analysts will review this for insights into the company's performance.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report detailing operational and financial information, with no immediate indication of significant negative events.
Key Players & Entities
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (company) — Registrant
- PACB (company) — Ticker Symbol
- May 8, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 1305 O'Brien Drive Menlo Park, California 94025 (address) — Principal Executive Offices
FAQ
What specific financial results are being reported in this 8-K?
The provided excerpt of the 8-K filing indicates that it concerns 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits,' but does not detail specific financial figures.
When was this 8-K report filed?
The report was filed on May 8, 2025.
What is the company's principal executive office address?
The principal executive offices are located at 1305 O'Brien Drive, Menlo Park, California 94025.
What is the ticker symbol for Pacific Biosciences of California, Inc.?
The ticker symbol is PACB.
What is the state of incorporation for Pacific Biosciences of California, Inc.?
The company is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 8, 2025 regarding PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB).